Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 68.90
+0.60 (0.88%)
Nov 4, 2026, 1:27 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 381.17 million as of November 3, 2026. It is the 25,234th most valuable company in the world and the 150th biggest in Poland. Its market cap has decreased by 19.95% in one year.
Market Cap
381.17M
Enterprise Value
324.51M
Revenue
n/a
Global Rank
Country Rank
#150 Poland
PE Ratio
n/a
ChartMarket Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 381.17M, an increase of 231.35%. That is a compound annual growth rate of 27.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 381.17M | -0.25% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 527.59M |
| Ryvu Therapeutics | 380.10M |
| Captor Therapeutics Spolka Akcyjna | 329.11M |
| BIOTON | 287.22M |
| Synthaverse | 200.69M |
| Mabion | 127.20M |
| Poltreg | 124.25M |
| Molecure | 118.67M |